27 January 2025
#Twenty25 - Funding the future of health tech - Part 13/20 Interview with Ruth Coleman, Mercia Ventures
Predicting the future is a tricky thing. In 1989, the movie Back to the Future II painted 2015 as a picture of flying cars, hologram movies and hoverboards being mainstream. While that future hasn't quite materialized, the world of technology, especially health tech, has seen remarkable advancements.
Now that 2024 is behind us and we enter the second quarter of the century, Coulter Partners sought insights from twenty early-stage investors in health tech. We asked them three key questions:
- Where will health tech investment go in 2025?
- What trends or segments will drive health tech growth beyond 2025?
- If given a magic wand, what change would significantly accelerate health tech's impact?
In the thirteenth interview of our Health Tech Investors series, Ian Coyne spoke to Ruth Coleman, Investment Manager at Mercia Ventures.
Ian Coyne: Let’s talk about the three horizons. One is 2025, what do you think will be interesting in health tech? What's current? The second is beyond that, what are the big themes or focus areas or technologies you think will be really interesting? And the third is if you had a magic wand and could change anything to accelerate innovation, what would that look like?
Ruth Coleman:
AI is set to continue transforming healthcare innovation, with a notable shift towards multimodal AI technologies. These advancements represent a significant evolution from today's point-solution AI systems. As the AI healthcare landscape becomes increasingly competitive, these point solutions will find it more difficult to compete.
Multimodal AI holds immense transformative potential for healthcare due to its ability to integrate and analyze diverse datasets—spanning notes, test, lab results, omics, and audio—by reading, seeing, hearing, and sensing. This integration will enhance triaging, diagnosis, treatment, and care coordination. This will alleviate the administrative burden on clinicians, addressing a critical challenge in an overburdened healthcare system
Ian: Are there any business models you think will be more attractive in 2025?
Ruth: Direct-to-consumer models will continue to grow. I believe more and more consumers care about their own health and are becoming more willing to pay for their own healthcare, especially on the prevention side.
Tech-enabled services is an interesting business model, by definition the human in already in the loop, which from a workflow and acceptability perspective makes adoption easier. Margins within this segment has made it difficult to find winners, but there are clear opportunities to enhance efficiencies with AI making it more attractive.
Ian: How comfortable do you think people will be knowing they're speaking to AI in a medical sense?
Ruth: I think you'll always need a human within the loop in healthcare. There will be interactions with AI, but a person will provide the final decision-making. It's important to have human logic checkpoints on top of AI.
Ian: If you had a magic wand, what would you change to accelerate health tech innovation?
Ruth: I would turn the existing healthcare system on its head so that it rewards providers to provide proactive coordinated prevention orientated care rather than the existing one which tends to be more a reactive form of healthcare provision. There are too many incredible preventative health tech innovations that could save patients’ lives but do not see the light of day because of this fundamental issue in the incentive structure.
---
Ruth Coleman, Investment Manager at Mercia Ventures
Ruth is an Investment Manager for Mercia’s EIS Team with a focus on investing in early and growth stage technology companies. Based in London, Ruth’s role focuses on sourcing, transacting, and managing investments for the southeast region.
About Mercia Ventures
We’ve seen what it takes to build great companies and we work closely with founders to achieve this goal together. Key to this success, Mercia’s Nucleus offers a dedicated and focused team to support value creation aligned to founders’ needs.
https://www.mercia.co.uk/ventures/
Related
-
Thought Leadership
#Twenty25 - Funding the future of health tech - Part 16/20 Interview with Marta Mrozowicz, Heal Capital
29 January 2025
-
Thought Leadership
#Twenty25 - Funding the future of health tech - Part 15/20 Interview with Douwe Jippes, Healthy.Capital
29 January 2025
-
Thought Leadership
#Twenty25 - Funding the future of health tech - Part 8/20 Interview with Melanie Haynes, Bethnal Green Ventures (BGV)
16 January 2025
-
Thought Leadership
#Twenty25 - Funding the future of health tech - Part 7/20 Interview with Dominick Kennerson, HSBC Innovation Banking
15 January 2025